Abstract
Renal cell carcinoma (RCC) accounts for over 85% of all solid kidney tumors and is the third most common genitourinary malignancy after carcinoma of the prostate and bladder. Approximately 28–33,000 new cases of RCC are diagnosed per year in the United States, accounting for 3% of all adult malignancies, with an incidence roughly equal to that of all forms of leukemia combined (1). Over one third of patients with RCC will ultimately die of their disease. Despite the increase in incidentally discovered tumors due to the widespread use of noninvasive radiographic imaging techniques (2–4), 25–30% of patients present with locally advanced or metastatic disease (5). Delay in diagnosis may result from the ability of space occupying lesions of the retroperitoneum to become quite large before causing local symptoms. Additionally, manifestations of RCC are protean and may give rise to a constellation of nonspecific symptoms causing delayed detectionordiscovery ofthe lesionwhile pursuing otherdiagnoses. Finally, microscopic hematuria may go undetected while gross hematuria, which may occur only after the primary lesion has reached considerable size, may be improperly misattributed to other causes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Parker SL, Tong T, Bolden S, and Windo PA. Cancer Statistics, CA 47 (1997) 5–27.
Vallancien G, Torres LO, Gurfinkel E, Veillon B, and Brisset JM. Incidental detection of renal tumours by abdominal ultrasonography, Eur. Urol., 18 (1990) 94.
Jayson M and Sanders H. Increased incidence of serendipitously discovered renal cell carcinoma, Urology, 51 (1998) 203.
Smith SJ, Bosniak MA, Megibow AJ, Hulnick DH, Horri SC, and Raghavendra BN, Renal cell carcinoma: earlier-discovery and increased detection, Radiology, 170 (1989) 699.
Linehan WM, Shipley WU, and Parkinson DR. Cancer of the kidney and ureter. In Cancer: Principles and Practice of Oncology, DeVita VT, Hellman S, and Rosenberg SA (eds.), JB Lippincott, Philadalphia, PA, 1993, pp. 1023–1051.
Aguirre A, Rinaggio J, and Diaz-Ordaz E. Lingual metastatis of renal cell carcinoma, J. Oral Maxillofac. Surg., 54 (1996) 344–346.
Green KM, Pantelides E, and de Carpentier JP. Tonsillar metasasis from a renal cell carcinoma presenting as a quinsy, J. Laryngol. Otol. 111 (1997) 379, 380.
Shimizu K, Nagahama M, Kitamura Y, Chin K, Kitagawa W, Shibuya T, et al. Clinopathological study of clear-cell tumors of the thyroid: an evaluation of 22 cases, Surg. Today, 25 (1995) 1015–1022.
Murakami S, Yashuda S, Nakamura T, Mishima Y, Iida H, Okano H, and Nakano M. A case of renal cell caracinoma with metastasis to the thryoid gland and concomitant early gastic cancer, Surg. Today, 23 (1993) 153–158.
Parnes RE, Goldberg SH, and Sassani JW. Renal cell carcinoma metastatic to the orbit: a clinicopathologic report, Ann. Ophthalmol., 25 (1993) 100–102.
Mezer E, Gdal-On M, and Miller B. Oribital metastasis of renal cell caracinoma masquerading as Amaurosis fugax. Europ. J. Ophthal., 7 (1997) 301–304.
Pursner M, Petchprapa C, Haller JO, and Orentlicher RJ. Renal carcinoma: bilateral breast metastases in a child, Ped. Radiol., 27 (1997) 242, 243.
Kannan V. Fine-needle aspariation of metastatic renal cell carcinoma masquerading as primary breast carcinoma, Diag. Cytopathol., 18 (1998) 343–345.
Pagano S, Ruggeri P, Franzoso F, and Brusamolino R. Unusual renal cell caracinoma metastasis to the gallbladder, Urology, 45 (1995) 867–869.
Golbey S, Gerard PS, and Frank RG. Metastataic hypernephroma masquerading as acute cholecystitis, Clin. Imag., 15 (1991) 293–295.
Fabre JM, Rouanet P, Dagues F, Blanc F, Baumel H, and Domergue J. Various features and surgical approach of solitary pancreatic metastasis from renal cell carcinoma, Europ. J. Surg. Oncol., 21 (1995) 683–686.
Odori T, Tsuboi Y, Katoh K, Yamada K, Morita K, Ohara A, et al. A solitary hematogenous metastasis to the gastric wall from renal cell carcinoma four years after radical nephrectomy, J. Clin. Gastroenterol., 26 (1998) 153, 154.
Bird DJ, Semple JP, and Seiler MW. Sarcomatoid renal cell carcinoma metastatic to the heart: report of a case, Ultrastruct. Pathol., 15 (1991) 361–366.
Fallicl ML, Long JP, and Ucci A. Metachronous renal cell carcinoma metastases to spermatic cord and penis, Scand. J. Urol. Nephrol., 31 (1997) 299–300.
Yamamoto S, Mamiya Y, Noda K, Samejima T, Miki M, and Akasaka Y. A case of metastasis to the seminal vesicle of renal cell carcinoma, Jap. J. Urol., 89 (1998) 563–566.
Bolkier M, Moskovitz B, Munichor M, Genesin Y, and Levin DR. Metastatic renal cell carcinoma to the bladder, Urol. Internat., 50 (1993) 101–103.
Ovesen H and Gerstenberg T. Vaginal metastasis as the first sign of renal cell carcinoma. A case report and review of the literature, Scand. J. Urol. Nephrol., 24 (1990) 237–238.
Merimsky O, Levine T, and Chaitchik S. Recurrent solitary metastasis of renal cell carcinoma in skeletal muscles, Tumor, 76 (1990) 407–409.
Nakagawa H, Mizukami Y, Kimura H, Watanabe Y, and Kuwayama N. Metastatic masseter muscle tumour: a report of a case, J. Laryngol. Otol., 110 (1996) 172–174.
Linn JF, Fichtner J, Voges G, Schweden F, Storkel S, and Hohenfellner R. Solitary contralateral psoas metastasis 14 years after radical nephrectomy for organ confined renal cell carcinoma, J. Urol., 156 (1996) 173.
Ditonno P, Traficante A, Battaglia M, Grossi FS, and Selvaggi FP. Role of lymphadenectomy in renal cell carcinoma, Prog. Clin. Biol. Res., 378 (1992) 169–174.
Fowler JE. Nephrectomy in metastatic renal cell carcinoma, Urol. Clin. N. Amer., 14 (1987) 749–756.
Sokoloff MH, deKernion JB, Figlin RA, and Belldegrun A. Current management of renal cell carcinoma, Ca: Can. J. Clin., 46 (1996) 284–302.
Bostwick DG and Murphy GP. Diagnosis and prognosis of renal cell carcinoma: highlights from an international consensus workshop, Semin. Urol. Oncol., 16 (1998) 46–52.
Cadeddu JA, Woshinari O, Clayman RV, Barrett PH, Janetschek G, Fentie DD, et al. Laparoscopic nephrectomy for renal cell cancer: evaluation of efficacy and safety: a multi-center experience, J. Urol., 52 (1998) 773–777.
Selli C, Hinshaw WM, Woodward BH, and Paulson DF. Stratification of risk factors in renal cell carcinoma, Cancer, 52 (1983) 899–903.
Everson TC and Cole WH (eds.). Spontaneous Regression of Cancer, WB Saunders, Philadelphia, PA, 1996.
Myers GH, Fehrenbaker LG, and Kellais PP. Prognostic significance of renal vein invasions by hypernephroma, J. Urol., 100 (1968) 420.
Oliver RTD. Surveillance as a possible option for management of metastatic renal cell carcinoma, Semin. Urol., 7 (1989) 149.
van der Werf-Messing B and van Gilse HA. Hormonal treatment of metastases of renal carcinoma, Brit. J. Cancer, 25 (1971) 423.
Guthbjansson T and Gislason T. Spontaneous regression of brain metastasis secondary to renal cell carcinoma, Scand. J. Urol. Nephrol., 29 (1995) 215.
Omland H and Fossa SD. Spontaneous regression of cerebral and pulmonary metastases in renal cell carcinoma, Scand. J. Urol. Nephrol., 23 (1989) 159–160.
Kerbl K and Pauer W. Spontaneous regression of osseous metastasis in renal cell carcinoma, Austral. N. Zeal. J. Surg., 63 (1993) 901.
de la Figuera M, Biosca M, and Garcia-Bragado F. Spontaneous regression of bilateral hilar lymphadenopathy in renal cell carcinoma, Europ. J. Resp. Dis., 67 (1985) 133.
Ritchie AW, Layfield LJ, and deKernion JB. Spontaneous regression of liver metastasis from renal cell carcinoma, J. Urol., 40 (1988) 596.
Bos SD and Mensink HJ. Spontaneous caval tumor thrombus necrosis and regression of pulmonary lesions in renal cell cancer, Scand. J. Urol. Nephrol., 30 (1996) 489.
Vogelzang NJ, Priest ER, and Borden L. Spontaneous regression of histologically proved pulmonary metastases from renal cell carcinoma: a case with 5-year follow-up, J. Urol., 148 (1992) 1247.
Wagner JR, Merino MJ, Pass HI, Linehan WM, and Walther MM. Pulmonary infarcts can mimic pulmonary metastases from renal cancer, J. Urol., 158 (1997) 1688.
Kozlowski JM. Management of distal solitary recurrence in the patient with renal cancer, Urol. Clin. N. Amer., 21 (1994) 601.
Abubakr YA, Chou TH, and Redman BG. Spontaneous remission of renal cell carcinoma: a case report and immunological correlates, J. Urol., 152 (1994) 156.
Uzzo RG, Clark PE, Rayman P, Bloom T, Rybicki L, Novick AC, Bukowski RM, and Finke JH. Alterations in NFuB activation in T lymphocytes of patients with renal cell carcinoma, J. Natl. Cancer, Instit., 91 (1999) 718–721.
Wang Q, Redovan C, Tubbs R, Olencki T, Klein E, Kudoh S, et al. Selective cytokine gene expression in renal cell carcinoma tumor cells and tumor-infiltrating lymphocytes, Internatl. J. Cancer, 61 (1995) 780–785.
O’Reilly MS, Holmgren L, Shing C, Chen RA, Rosenthal M, Moses WS, Lane Y, Cao EH, and Folkman J. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma, Cell, 79 (1994) 315–328.
Kavolius JP, Mastorakos DP, Pavlovich C, Russo P, Burt ME, and Brady MS. Resection ofmetastatic renal cell carcinoma, J. Clin. Oncol., 16 (1998) 2261–2266.
Middleton RG. Surgery for metastatic renal cell carcinoma, J. Urol., 97 (1967) 973–977.
Tolia BM and Whitmore WF. Solitary metastases from renal cell carcinoma, J. Urol., 114 (1975) 836–838.
O’Dea MJ, Zincke H, Utz DC, and Bernatz PE. The treatment of renal cell carcinoma with solitary metastasis, J. Urol., 120 (1978) 540–542.
Golimbu M, Al-Askari S, Tessler A, and Morales P. Aggressive treatment of metastatic renal cancer, J. Urol., 136 (1986) 805–807.
deKernion JB, Ramming KP, and Smith RB. The natural history of metastatic renal cell carcinoma a computer analysis. J. Urol., 120 (1978) 148–152.
Cerfolio RJ, Allen MS, Deschamps C, Daly RC, Wallrichs SL, Trastek VF, and Pairolero PC. Pulmonary resection of metastatic renal cell carcinoma, Ann. Thor. Surg., 57 (1994) 339–344.
Kozlowski JM. Management of distal solitary recurrence in the patient with renal cancer, Urol. Clin. N. Amer., 21 (1994) 601–624.
Fallick ML, McDermott DF, LaRock D, Long JP, and Atkins MB. Nephrectomy before interleukin-2 therapy for patients with metastatic renal cell carcinoma, J. Urol., 158 (1997) 1691–1695.
Taneja SS, Pierce W, Figlin R, and Belldegrun A. Immunotherapy for renal cell carcinoma: the era of interleukin-2-based treatment, Urology, 45 (1995) 911–924.
Rackley R, Novick A, Klein E, Bukowski R, McLain D, and Goldfarb D. The impact of adjuvant nephrectomy on multimodality treatment of metastatic renal cell carcinoma, J. Urol., 152 (1994) 1399–1403.
Walther MM, Yang JC, Pass HI, Linehan WM, and Rosenberg SA. Cytoreductive surgery before high dose interleukin-2 based therapy in patients with metastatic renal cell carcinoma, J. Urol., 158 (1997) 1675–1678.
Kono K, Salazar-Onfray F, Petersson M, Hansson J, Masucci G, Wasserman K, et al. Hydrogen peroxide secreted by tumor derived macrophages down modulates signal transducing zeta molecules and inhibits tumor specific T cell and natural killer cell mediated cytotoxicity, Eur. J. lmmunol., 26 (1996) 1308–1313.
Cummings KB and Robertson RP. Prostaglandin: increased production by renal cell carcinoma, J. Urol., 118 (1977) 720–723.
Romano MF, Lamberti A, Petrell A, Bisogni R, Tassone PF, Formisano S, Venuta S, and Turco MC. IL-10 inhibits nuclear factor-kappa B/Rel nuclear activity in CD3-stimulated human peripheral T lymphocytes, J. Immunol., 156 (1996) 2119–2123.
Uzzo RG, Rayman P, Kolenko V, Clark PE, Cathcart MK, Bloom T, et al. Suppression of NFuB activation in T cells by soluble products from renal cell carcinomas is mediated by tumor derived gangliosides, J. Clin. Invest., 104 (1999) 769–776.
Uzzo RG, Rayman P, Kolenko V, Clark PE, Bloom T, Molto L, et al. Mechanisms of apoptosis in T cells from patients with renal cell carcinoma, Clin. Cancer Res., 5 (1999) 1219–1229.
Finke JH, Rayman P, Edinger M, Tubbs RR, Stanley J, Klein E, and Bukowski R. Characterization of a human renal cell carcinoma specific cytotoxic CD8+ T cell line, J. Immunother., 11 (1992) 1–11.
Broder S and Waldmann TA. The suppressor-cell network in cancer, N. Engl. J. Med., 299 (1978) 1281–1284.
Wang Q, Redovan C, Tubbs R, Olencki T, Klein E, Kudoh S, Finke J, and Bukowski RM. Selective cytokine gene expression in renal cell carcinoma tumor cells and tumor-infiltrating lymphocytes, Intl. J. Cancer, 61 (1995) 780–785.
Bukowski RM, Murthy SR, Klein EA, Bauer L, Tubbs RR, Budd GT, et al. Tumor-infiltrating lymphocytes in metastatic renal cell carcinoma. In Renal Cell Carcinoma: Immunotherapy and Cellular Biology. Klein EA, Bukowski RM, and Finke JH (eds.), Marcel Dekker, New York, NY, 1993, pp. 127–137.
Liu J, Finke J, Kraus JC, Shu S, and Plautz GE. Ex vivo activation of tumor-draining lymph node T cells reverses defects in signal transduction molecules, Cancer Immunol. Immunother., 46 (1998) 268–276.
Mulders P, Tso CL, Gitlitz B, Kaboo R, Hinkel A, Frand S, et al. Presentation of renal tumor antigens by human dendritic cells activates tumor infiltrating lymphocytes against autologous tumor: implications for live kidney cancer vaccines, Clin. Cancer Res., 5 (1999) 445–454.
Montie JE, Stewart BH, Straffon RA, Banowsky LHW, Hewitt CB, and Montague DK. The role of adjunctive nephrectomy in patients with metastatic renal cell carcinoma, J. Urol., 117 (1977) 272–275.
Lanigan D, Jurriaans E, Hammonds JC, Wells IP, and Choa RG. The current status of embolization in renal cell carcinoma—a survey of local and national practice, Clin. Radiol., 46 (1992) 176–178.
Bottiger LE. Prognosis in renal carcinoma, Cancer, 26 (1970) 780–787.
Rafla S. Renal cell carcinoma, Cancer, 25 (1970) 26–40.
Thompson IM, Shannon H, Ross GJ, and Montie J. An analysis of factors affecting survival in 150 patients with renal cell carcinoma, J. Urol., 114 (1975) 694–696.
Klugo RC, Detmers M, Stiles RE, Talley RW, and Cerney JC. Aggressive versus conservative management of stage IV renal cell carcinoma, J. Urol., 118 (1977) 244–246.
Giuliani L, Giberti C, Martorana G, and Rovida S. Radical extensive surgery for renal cell carcinoma: long-term results and prognostic factors, J. Urol., 143 (1990) 468–473.
Dineen MK, Pastore RD, Emrich LJ, and Huben RP. Results of surgical treatment of renal cell carcinoma with solitary metastasis, J. Urol., 140 (1988) 277–279.
Kierney PC, van Heerden JA, Segura JW, and Weaver AL. Surgeon’s role in the management of solitary renal cell carcinoma metastases occurring subsequent to initial curative nephrectomy: an institutional review, Ann. Surg. Oncol., 1 (1994) 345–352.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer Science+Business Media New York
About this chapter
Cite this chapter
Uzzo, R.G., Novick, A.C. (2000). The Role of Nephrectomy and Metastasectomy for Advanced Renal Cell Carcinoma. In: Bukowski, R.M., Novick, A.C. (eds) Renal Cell Carcinoma. Current Clinical Oncology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-229-6_14
Download citation
DOI: https://doi.org/10.1007/978-1-59259-229-6_14
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4757-6401-7
Online ISBN: 978-1-59259-229-6
eBook Packages: Springer Book Archive